Best Researcher Award

Windingoudi Rimwagna Christian Ouédraogo — Institut de Recherche en Sciences de la Santé, Burkina Faso.

Windingoudi Rimwagna Christian Ouédraogo
Affiliation Institut de Recherche en Sciences de la Santé
Country Burkina Faso
Scopus ID 58145355200
Documents 4
Citations 10
h-index 1
Subject Area Pharmacology
Event Scientific World Research Awards
ORCID 0000-0001-8365-5579

Windingoudi Rimwagna Christian Ouédraogo is a pharmacology researcher. His documented research activities include pharmacological investigations of medicinal plants, natural products, cardiovascular effects, and experimental models of disease.[1]

Abstract

This profile presents the research activities and scholarly publications of Windingoudi Rimwagna Christian Ouédraogo, whose work focuses on pharmacology and medicinal plant research. His documented publications investigate plant-derived extracts, biological activity, toxicity, vascular protection, and potential therapeutic applications.[1]

Keywords

Pharmacology, medicinal plants, natural products, phytochemistry, cardiovascular research, antihypertensive activity, antioxidant activity, toxicity assessment, vascular endothelium, and drug discovery.

Introduction

Pharmacological research examines the biological effects of substances and their potential therapeutic applications. Research into medicinal plants contributes experimental evidence concerning chemical constituents, safety, and biological activity. Ouédraogo’s listed publications reflect these themes through investigations involving plant extracts and experimental cardiovascular models. [2]

Research Profile

According to his research record, Ouédraogo has worked as a Pharmacology Research Engineer at the Institut de Recherche en Sciences de la Santé since December 2019. His recorded keywords include pharmacology, phytochemistry, natural products, medicinal plants, and life and human sciences. [1]

Research Contributions

His studies investigate the pharmacological properties of plant extracts, including potential antihypertensive, antioxidant, and vascular protective effects. Other publications examine acute toxicity, phytochemical profiles, and experimental therapeutic effects. These studies contribute to the scientific investigation of natural products without, by themselves, establishing clinical efficacy in humans. [3]

Publications

The ORCID record lists six works, including studies published in 2023, 2024, 2025, and 2026. Examples include research on Phaseolus vulgaris extracts and vascular protection, Flemingia faginea phenolic compounds, and the pharmacological effects of Ampelocissus africana. The record covers the associated journals and DOIs for the publications. [1]

Research Impact

The bibliometric figures are four documents, ten citations, and an h-index of one. These figures are profile data and should be checked against the current Scopus record before formal publication. Citation counts and h-index values describe selected aspects of scholarly output but do not independently establish research quality or practical impact. [4]

Award Suitability

The Best Researcher Award category may recognize contributions to scientific investigation, publication, collaboration, and disciplinary development. Ouédraogo’s documented pharmacology publications provide material for consideration within this category. Eligibility and final award decisions should follow the official event criteria and independent verification of the researcher’s achievements. [5]

Conclusion

Windingoudi Rimwagna Christian Ouédraogo’s recorded research focuses on pharmacology, medicinal plants, and the investigation of biologically active natural products. His published studies provide verifiable starting points for evaluating his academic profile. Recognition should be based on documented achievements and the award organizer’s published assessment criteria.

References

  1. ORCID. (n.d.). Windingoudi Rimwagna Christian Ouédraogo: Researcher record and works. ORCID.
    https://orcid.org/0000-0001-8365-5579
  2. Ouédraogo, W. R. C., et al. (2026). Antihypertensive and Vascular Endothelium Protection Effect of the Ethyl Acetate Fraction of Phaseolus vulgaris Pods in L-NAME-induced Hypertensive Mice. Biomedical & Pharmacology Journal.
    https://doi.org/10.13005/bpj/3524
  3. Ouédraogo, W. R. C., et al. (2026). Evaluation of organic acids, cytotoxicity, oral acute toxicity and diuretic effect of Phaseolus vulgaris crops ethyl acetate extract for cardiovascular health improvement. Journal of Drug Delivery and Therapeutics.
    https://doi.org/10.22270/jddt.v16i5.7765
  4. Elsevier. (n.d.). Scopus author details: Windingoudi Rimwagna Christian Ouédraogo, Author ID 58145355200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58145355200
  5. Scientific World Research Awards. (n.d.). Official award website.
    https://scientificworld.net/
Windingoudi Rimwagna Christian Ouédraogo | Pharmacology | Best Researcher Award

You May Also Like